• C-Mer Medical repurchased 240,000 ordinary shares on-market on July 13, 2026, per an HKEX next-day disclosure return.
• Buyback price range HKD 0.93 to HKD 0.94 per share; aggregate consideration HKD 223,400.
• Total repurchased/cancelled shares: 240,000 repurchased; 0 cancelled.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. C-Mer Medical Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260713-12242466), on July 13, 2026, and is solely responsible for the information contained therein.